CureGenetics logo

CureGenetics

CureGenetics is a biotechnology company using CRISPR to develop cellular therapies, gene therapies, and molecular diagnostic tools.

2

Funding Rounds

$34.0m

Money raised

Overview

CureGenetics is a biotechnology company using CRISPR to develop cellular therapies, gene therapies, and molecular diagnostic tools.

Funding series

Funding Series Analysis

The company CureGenetics has raised a total of $17m in funding over 2 rounds.

Key Insights:

  • CureGenetics Series A round, August 2018: $17m
  • CureGenetics funding round, August 2018: $17m
CureGenetics logo
CureGenetics Series A round, August 2018 $17m
CureGenetics logo
CureGenetics funding round, August 2018 $17m